Brief: Olema Oncology Q4 Net Income USD -26.772 Million
11/03/2024 20:03
Mar 11 (Reuters) - Olema Oncology Q4 basic EPS USD -0.49 vs. IBES estimate USD -0.48. * Q4 operating expenses USD 30.416 million * Q4 income from operations USD -30.416 million
Recent news on Olema Oncology
See all newsBrief: Olema Pharmaceuticals Changes Corporate Name To Olema Oncology, Effective Today
Olema Pharmaceuticals, Inc. reports results for the quarter ended September 30 - Earnings Summary
Olema Pharma Q3 net loss widens on higher costs
Brief: Olema Pharmaceuticals Q3 Net Income USD -73.599 Million
Olema Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary